Biochemical basis of breast cancer treatment by androgens and progestins.
D000728:Androgens / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004351:Drug Resistance; D004965:Estrogen Antagonists / Q000494:pharmacology; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism; D009376:Neoplasms, Hormone-Dependent / Q000378:metabolism; D009649:Norpregnadienes / Q000627:therapeutic use*; D011397:Promegestone / Q000627:therapeutic use*; D051381:Rats; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism
D000728:Androgens; D004965:Estrogen Antagonists; D009363:Neoplasm Proteins; D009649:Norpregnadienes; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D011397:Promegestone